logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Forbes, Alexandria Josefina
    Born in July 1964
    Individual (9 offsprings)
    Officer
    icon of calendar 2015-04-10 ~ now
    OF - Director → CIF 0
  • 2
    Giroux, Richard Brian, Mr.
    Born in September 1972
    Individual (7 offsprings)
    Officer
    icon of calendar 2020-02-14 ~ now
    OF - Director → CIF 0
  • 3
    KADMON GENE THERAPY LIMITED - 2015-04-08
    KADMON GENE THERAPY HOLDINGS LIMITED - 2015-06-10
    icon of addressBritannia Walk, 92 Britannia Walk, London, England
    Active Corporate (3 parents, 5 offsprings)
    Person with significant control
    icon of calendar 2016-04-10 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
Ceased 1
  • Waksal, Samuel David
    Chairman born in August 1947
    Individual
    Officer
    icon of calendar 2015-04-10 ~ 2015-10-08
    OF - Director → CIF 0
parent relation
Company in focus

MEIRAGTX UK LIMITED

Previous name
KADMON GENE THERAPY LIMITED - 2015-06-10
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Called-up share capital not yet paid and not classified as a current asset
1 GBP2021-12-31
1 GBP2020-12-31
Net Assets/Liabilities
1 GBP2021-12-31
1 GBP2020-12-31
Number of shares allotted
Class 1 ordinary share
1 shares2021-01-01 ~ 2021-12-31
Par Value of Share
Class 1 ordinary share
1 GBP2021-01-01 ~ 2021-12-31
Equity
1 GBP2021-12-31
1 GBP2020-12-31

  • MEIRAGTX UK LIMITED
    Info
    KADMON GENE THERAPY LIMITED - 2015-06-10
    Registered number 09535413
    icon of address92 Britannia Walk, London N1 7NQ
    PRIVATE LIMITED COMPANY incorporated on 2015-04-10 (10 years 9 months). The company status is Active.
    The last date of confirmation statement was made at 2025-04-10
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.